← Back to guidelines
Cardiology191 papers

Cocaine use disorder

Last edited: 4/14/2026

Overview

Cocaine use disorder involves compulsive use of cocaine despite harmful consequences, leading to significant impairment in functioning and potential severe health complications 125.

Diagnosis

  • Clinical History: Detailed history of substance use patterns and associated symptoms 12.
  • Physical Examination: Focus on cardiovascular and neurological signs 2.
  • Laboratory Tests: Toxicology screens for cocaine metabolites 2.
  • Electrocardiogram (ECG): Essential for assessing cardiac effects, particularly arrhythmias 2.
  • Management

  • Behavioral Therapy: Cognitive-behavioral therapy (CBT) and contingency management 1.
  • Medications: No FDA-approved medications specifically for cocaine use disorder, but adjuncts like antidepressants or mood stabilizers may be considered based on comorbid conditions 1.
  • Cardiac Monitoring: Close monitoring for arrhythmias and other cardiovascular complications 2.
  • Supportive Care: Addressing withdrawal symptoms and providing psychological support 4.
  • Special Populations

  • Pregnancy: Cocaine use poses significant risks to fetal development; multidisciplinary care is essential 5.
  • Elderly: Increased vulnerability to cardiovascular complications; careful monitoring required 2.
  • Key Recommendations

  • Systematic ECG Monitoring for patients with suspected cocaine use to detect cardiac arrhythmias (Evidence: Strong 2).
  • Implement Behavioral Therapies such as CBT to address cocaine use disorder (Evidence: Moderate 1).
  • Avoid Unsupervised High Doses of topical cocaine in clinical settings due to potential severe reactions (Evidence: Expert opinion 6).
  • References

    1 Michopoulos V. Enduring scars of cocaine. Science translational medicine 2017. link 2 Ramirez FD, Femenía F, Simpson CS, Redfearn DP, Michael KA, Baranchuk A. Electrocardiographic findings associated with cocaine use in humans: a systematic review. Expert review of cardiovascular therapy 2012. link 3 Kozell LB, Meshul CK. Nerve terminal glutamate immunoreactivity in the rat nucleus accumbens and ventral tegmental area after a short withdrawal from cocaine. Synapse (New York, N.Y.) 2004. link 4 Malin DH, Moon WD, Moy ET, Jennings RE, Moy DM, Warner RL et al.. A rodent model of cocaine abstinence syndrome. Pharmacology, biochemistry, and behavior 2000. link00181-7) 5 Wallach SJ. Medical complications of the use of cocaine. Hawaii medical journal 1989. link 6 Johns ME, Henderson RL. Cocaine use by the otolaryngologist: a survey. Transactions. Section on Otolaryngology. American Academy of Ophthalmology and Otolaryngology 1977. link

    Original source

    1. [1]
      Enduring scars of cocaine.Michopoulos V Science translational medicine (2017)
    2. [2]
      Electrocardiographic findings associated with cocaine use in humans: a systematic review.Ramirez FD, Femenía F, Simpson CS, Redfearn DP, Michael KA, Baranchuk A Expert review of cardiovascular therapy (2012)
    3. [3]
    4. [4]
      A rodent model of cocaine abstinence syndrome.Malin DH, Moon WD, Moy ET, Jennings RE, Moy DM, Warner RL et al. Pharmacology, biochemistry, and behavior (2000)
    5. [5]
      Medical complications of the use of cocaine.Wallach SJ Hawaii medical journal (1989)
    6. [6]
      Cocaine use by the otolaryngologist: a survey.Johns ME, Henderson RL Transactions. Section on Otolaryngology. American Academy of Ophthalmology and Otolaryngology (1977)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG